Inactive Instrument

Sector Chart Urovant Sciences Ltd.

Equities

UROV

BMG9381B1081

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
114B
107B
22.22B -
21.28B -
18.8B
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW